| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), LIXT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 100.0K | - | - | |
| Dir | 65.0K | - | - | |
| Dir | 25.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2018 | Riggs Arthur | 10% Owner | Buy | 1,260,000 | $0.50 | $630,000.00 | +26.0% | |
| Jan 11, 2017 | Schwartzberg Gil | 10% Owner | Buy | 1,005,556 | $0.06 | $59,327.80 | +12.4% | |
| Feb 19, 2016 | Forman Eric | 10% Owner | Buy | 53,500 | $0.30 | $15,963.00 | +115.1% | |
| Feb 4, 2016 | Forman Eric | 10% Owner | Buy | 2,500 | $0.25 | $625.00 | +5.7% |